Xi Jinping: Provide strong technological support to win the battle against the pandemic.

China Xi Jinping · General Secretary of the Communist Party of China and President of the People's Republic of China

15 March 2020 · Military Medical Research Institute and Tsinghua University School of Medicine

Context
Xi Jinping visited the Military Medical Research Institute and Tsinghua University School of Medicine on March 15, 2020, to assess China's scientific progress against COVID-19.
Main themes
COVID-19 pandemic response, scientific and technological research breakthroughs, vaccine development, clinical treatment and drug development, epidemic prevention and control, traditional Chinese and Western medicine integration, public health emergency management, Party Central Committee leadership, testing technologies, virology and epidemiology
Duration
~18 min
60th percentile
Words
2,127
60th percentile
Sentences
64
42nd percentile
Readability
7
0th percentile
Grade
20.5
98th percentile
Syntax
3.47
93rd percentile
Vocabulary
2.33
79th percentile

Translated from Chinese

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 63%63%
  • Institutional 14%14%
  • Technological 8%8%
  • Ceremonial 6%6%
  • Geopolitical 5%5%
  • Economic 5%5%
  • Environmental 0%0%
  • Not in focus 0%

64 sentences in 16 paragraphs

During this visit to the Military Medical Research Institute and Tsinghua University School of Medicine for research, the main purpose is to investigate the progress of scientific research and breakthroughs in epidemic prevention and control, and to meet with the researchers working on the front lines of epidemic prevention and control.

The COVID-19 pandemic is the most significant public health emergency in China since the founding of the People's Republic, characterized by the fastest transmission speed, the widest range of infection, and the greatest difficulty in prevention and control. The Party Central Committee attaches great importance to this issue and has quickly made arrangements, treating epidemic prevention and control as a top priority, placing the safety and health of the people first, and proposing the overall requirements of firm confidence, working together, scientific prevention and control, and precise measures. It has clarified the overall goal of resolutely curbing the spread of the epidemic and decisively winning the battle against epidemic prevention and control. Under the strong leadership of the Party Central Committee, and through the hard work of all parties, the situation of epidemic prevention and control is currently showing a positive trend.

Not long ago, the Party Central Committee held a meeting to coordinate the advancement of COVID-19 epidemic prevention and control and economic and social development, during which I delivered a speech. I also chaired meetings of the Standing Committee of the Political Bureau of the Central Committee and the Political Bureau, analyzing the situation of COVID-19 epidemic prevention and control and studying key areas of focus for prevention and control. In these occasions, I emphasized that overcoming the epidemic relies on technological support, and we must integrate multidisciplinary forces to accelerate scientific research breakthroughs, speeding up the research and development process while ensuring scientific rigor and safety, striving to achieve breakthroughs as soon as possible and to produce practical and effective research results.

Since the outbreak of the epidemic, the national scientific and technological community has actively responded to the call of the Party Central Committee. A research task force composed of 12 departments, including science and technology and health, has been established, identifying five major areas of focus: clinical treatment and drug development, vaccine research, testing technologies and products, virology and epidemiology, and the construction of animal models. Interdisciplinary and cross-field research teams have been organized, with collaboration between research, clinical practice, and frontline prevention and control, and close cooperation among academia, industry, and research. In just over a month, we have made positive progress. Within a week, we determined the complete genomic sequence of the novel coronavirus and isolated the virus strain, sharing it globally in a timely manner; in response to the urgent needs of epidemic prevention and control, we launched various testing reagent products nationwide in phases; by repurposing existing drugs, developing new treatment methods, and integrating traditional Chinese and Western medicine, we quickly screened a batch of effective drugs and treatment plans for clinical frontline use; we advanced vaccine research through multiple technical routes; and through research on the virus's living environment and transmission routes, we provided a scientific basis for formulating and improving prevention and control strategies. At the same time, experts and scholars have provided timely responses and clarifications, stabilizing public sentiment and strengthening confidence, thus providing strong technological support for winning this tough battle against the epidemic.

In this major struggle, the vast number of scientific and technological workers have fully demonstrated a spirit of hard work and dedication, as well as a rigorous and pragmatic professional spirit, with a number of advanced models emerging. Here, on behalf of the Party Central Committee, I would like to express my heartfelt gratitude and sincere greetings to the many scientific and technological workers fighting on the front lines of epidemic prevention and control research!

Looking at the history of human development, the most powerful weapon humans have against diseases is science and technology. Humanity's victory over major disasters and epidemics cannot be separated from scientific development and technological innovation. Throughout history, there have been many medical writings and methods for preventing and treating epidemics in China. The "Book of Han: Annals of Emperor Ping" records that in the second year of the Yuan Shi era, "when the people were afflicted by epidemics, they vacated their residences to provide for medical treatment," proposing that "isolation" is an important measure for epidemic prevention. In the mid-Ming Dynasty, the "variolation" technique for preventing smallpox emerged in China. At the end of the 18th century, British scientist Edward Jenner invented the method of inoculating cowpox to prevent smallpox, and after generations of relentless efforts by scientists, a vaccine using inactivated smallpox virus was finally developed. With the development of modern medical technology and the continuous improvement of public health infrastructure, infectious diseases such as cholera, plague, and influenza, which once caused great harm to humanity, have gradually been effectively controlled. In recent years, science and technology have played an important role in combating major infectious diseases such as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), H1N1 influenza, and Ebola virus. Since the founding of the People's Republic of China, through major scientific and technological special projects for infectious diseases, there has been a significant improvement in research levels, technical capabilities, platform construction, and talent teams in the field of infectious disease prevention and control.

Currently, winning the people's war, overall war, and counter-offensive against the epidemic requires arduous efforts. We have not yet fully clarified the source and host of the COVID-19 pandemic, its transmission routes, pathogenic mechanisms, harmfulness and lethality, treatment plans, therapeutic drugs, and whether there are sequelae after patient recovery. The more we face this situation, the more we must insist on seeking answers and methods from science. I hope that the vast number of scientific and technological workers will bravely shoulder their responsibilities and take decisive action to quickly tackle the key and difficult issues in epidemic prevention and control, providing strong technological support for winning the people's war, overall war, and counter-offensive against the epidemic. In the next steps, we need to focus on the following areas.

First, strengthen the integration of drug and medical equipment research and development with clinical treatment to effectively improve the cure rate and reduce the mortality rate. As of March 1, there are still more than 7,300 severe and critically ill patients nationwide, with a significant number of daily deaths, mainly in Hubei and Wuhan. Doing everything possible to save more patients' lives is an urgent priority. Research breakthroughs must treat the rescue of critically ill patients as a top priority, reinforcing the support and service of research breakthroughs for frontline clinical treatment, and ensuring that clinical research and clinical treatment are coordinated, allowing research results to tilt more towards the clinical frontline. We must accelerate the drug development process, adhere to the integration of traditional Chinese and Western medicine, and expedite the promotion and application of effective drugs that have already been developed and screened, while also screening a batch of effective therapeutic drugs based on frontline treatment needs, exploring new treatment methods, and doing everything possible to prevent mild patients from progressing to severe cases, thereby effectively improving the cure rate. We should adopt advanced treatment methods such as convalescent plasma, stem cells, and monoclonal antibodies to enhance the treatment level for severe and critically ill patients, and minimize the mortality rate.

Second, promote the organic connection between vaccine research and development and the industrialization chain, preparing comprehensively for the potential normalization of prevention and control work. Vaccines, as special products for healthy individuals, are crucial for epidemic prevention and control, and safety requirements are paramount. We must accelerate the development of various existing vaccine technology routes while closely tracking foreign research progress, strengthening cooperation, and striving to promote clinical trials and market use of vaccines as soon as possible. We need to focus on the present while looking to the future, accelerating the establishment of a vaccine research and industrialization system led by enterprises and integrating industry, academia, and research, as well as establishing a national vaccine reserve system.

Third, coordinate research on virus tracing and its transmission routes to clarify where the pathogen comes from and where it goes. As experts have said, the virus in this epidemic is very cunning, and tracing work faces significant difficulties. At the same time, the development of new technologies provides new means for virus tracing, allowing us to assess the possibility of suspected animals as intermediate hosts based on the binding characteristics of viral proteins and different receptors, and to conduct epidemiological and tracing investigations using new technologies such as artificial intelligence and big data, improving accuracy and screening efficiency. Research on virus tracing and transmission routes is crucial for the entire epidemic prevention and control effort and must be pursued with full force.

Fourth, ensure psychological counseling for patient recovery and isolated individuals. The psychological recovery of patients requires a process, and many individuals isolated at home for extended periods may develop various psychological issues; the families of deceased patients also need psychological support. If this issue is not addressed properly, it could pose a risk to social stability. We must pay close attention to their mental health and mobilize all forces to comprehensively strengthen psychological counseling efforts.

Fifth, improve the epidemic prevention and control and public health research and development system that integrates peacetime and wartime efforts. Major infectious diseases and biological safety risks are significant challenges that concern national security and development, as well as social stability. We must treat biological safety as an important component of national overall security, adhering to the integration of peacetime and wartime, prevention and emergency response, and research and treatment prevention and control, while strengthening the construction of the epidemic prevention and control and public health research and development system and capabilities. We need to coordinate research forces from all aspects to enhance systemic resistance capabilities and levels. The accumulation of research and technical reserves during peacetime is foundational work; we must strengthen strategic planning and forward-looking layout, improve the epidemic prevention and control early warning and prediction mechanism, capture information in a timely and effective manner, and take responsive measures promptly. We should study and establish a command, action, and support system for research breakthroughs in the event of an emergency state due to epidemic spread, preparing emergency action guidelines in peacetime and quickly activating them in emergencies.

Major scientific and technological achievements in the fields of life safety and biological safety are also crucial national assets. The epidemic prevention and control and public health emergency system is an important component of the national strategic system. We must improve the new national system for tackling key core technologies, accelerate the layout of research forces in the fields of population health and biological safety, integrate national key research systems in life sciences, biotechnology, medical health, and medical equipment, establish a number of national clinical medical research centers, increase investment in scientific and technological research in the health sector, strengthen basic research in life sciences, and achieve breakthroughs in key core technologies for medical health, accelerating the enhancement of strategic scientific and technological strength and strategic reserve capabilities in epidemic prevention and control and public health. We must accelerate the filling of gaps in high-end medical equipment in China, expedite the tackling of key core technologies, break through these technological equipment bottlenecks, and achieve self-control of high-end medical equipment.

Sixth, we must persist in carrying out patriotic health campaigns. This is not simply about cleaning; it should involve work in multiple areas such as improving living environments, dietary habits, social mental health, and public health facilities, particularly resolutely eliminating the bad habit of consuming wild animals and advocating for civilized, healthy, and environmentally friendly lifestyles.

Seventh, strengthen international cooperation in epidemic prevention and control research. Public health safety is a common challenge faced by humanity and requires countries to work together. Currently, the COVID-19 pandemic is occurring in multiple countries, and we need to strengthen communication and cooperation with the World Health Organization and relevant countries, especially those with high incidence of the epidemic, in areas such as tracing, drugs, vaccines, and testing, sharing research data and information under the premise of ensuring national security, and jointly researching and proposing response strategies to contribute wisdom and strength to building a community with a shared future for mankind.

Finally, I hope that the vast number of scientific and technological workers will continue to work hard, treating epidemic prevention and control research as a major and urgent task for the scientific and technological community, unifying leadership, and collaboratively advancing research breakthroughs, producing more results, and living up to the trust of the Party Central Committee and the expectations of the people.